Institutional Ownership
Akari Therapeutics PLC
CUSIP 00972G405SPONSORED ADRQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
6
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Armistice Capital, LLC | 38.9K | $200.4K |
| 2 | Cresset Asset Management, LLC | 20.6K | $105.9K |
| 3 | Ifp Advisors, Inc | 181 | $932 |
| 4 | Sbi Securities Co., Ltd. | 5 | $26 |
| 5 | Morgan Stanley | 1 | $5 |
| 6 | Truvestments Capital LLC | 1 | $5 |